Discover health insights, fitness tips, and medical breakthroughs for a healthier life.
Pharmaceutical
AbbVie has agreed to acquire an experimental depression treatment from Gilgamesh Pharmaceuticals in a deal worth up to $1.2 billion, marking a significant step in the drugmaker’s push into next-generation psychiatric medicines. Under the agreement, AbbVie will acquire Gilgamesh’s lead asset, bretisilocin (GM-2505), an investigational therapy for
Health
The Food and Drug Administration (FDA) has approved the first-ever glucose monitoring system designed specifically for weight loss, developed by health-tech startup Signos. The decision, announced Wednesday, creates a new pathway for Americans seeking to manage their weight outside of traditional treatments like medication or surgery. A New Option Beyond
Health
Roughly one in three adults in the U.S. regularly struggles with insufficient sleep—a growing problem that has fueled demand for smarter tools to monitor, analyze, and improve rest. Eight Sleep, a New York-based startup founded in 2014, is betting big on AI-driven solutions to make sleep not just
Pharmaceutical
Varda Space is pushing the boundaries of pharmaceutical production by taking the process out of Earth’s gravity well and into orbit. The company announced a $187 million Series C funding round on Thursday to accelerate its mission of using space as a unique environment for drug manufacturing. With gravity
Biotechnology
Remember when DeepMind's AlphaFold cracked the decades-old protein folding problem and walked off with a Nobel Prize? That was just the beginning. Now, the Google-owned AI lab is taking aim at an even tougher challenge: deciphering the 98% of your genome we still barely understand. Meet AlphaGenome, DeepMind’
Healthcare
In a striking show of investor confidence, AI health tech startup Abridge has doubled its valuation to $5.3 billion just four months after its previous funding round. The Pittsburgh-based company has secured a $300 million Series E round, led by Andreessen Horowitz with continued backing from Khosla Ventures, according
Health
Digital health startup Sword Health has secured a fresh $40 million in funding at a $4 billion valuation, marking a 33% increase from its $3 billion valuation just a year ago. The round was led by returning backer General Catalyst, with participation from Khosla Ventures, Comcast Ventures, and several other
Healthcare
In a bold move to solidify its international presence, Hims & Hers Health announced Tuesday it will acquire Zava, a prominent European telehealth platform. The acquisition marks a pivotal step in the U.S.-based company's strategy to expand beyond domestic borders and tap into growing demand for
Biotechnology
Samsung’s venture capital arm is preparing to invest in California-based medical device startup Exo, as part of a funding round that could reach $100 million. The round is reportedly being led by Sands Capital, Bold Capital, and Qubit Health Capital. Notably, Qubit Health’s chairman, former Medtronic CEO Omar
Health
Strava, the widely used fitness tracking app, has raised a new round of funding that values the company at $2.2 billion, including debt. The announcement, made by CEO Mike Martin, signals a new chapter of expansion for the company, which has also confirmed its second acquisition in as many
Biotechnology
Pharmaceutical giant Regeneron announced Monday that it will acquire genetic testing company 23andMe for $256 million, following a court-supervised bankruptcy auction. The deal, if approved, will grant Regeneron ownership of 23andMe’s genomics service and a massive trove of personal and genetic data from roughly 15 million customers. The acquisition
Biotechnology
Biotech startup NewLimit, which is focused on extending healthy human lifespan through cellular reprogramming, has raised a $130 million Series B round led by Kleiner Perkins. The round also included new investors Nat Friedman, Daniel Gross, and Khosla Ventures, along with returning backers like Founders Fund, Dimension Capital, Elad Gil,